Antisense antibacterial compounds and methods
US11021706B2 · kind B2 · utility
0Cited by
23References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 1, 2017 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Sep 1, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are antisense morpholino oligomers targeted against bacterial virulence factors such as genes that contribute to antibiotic resistance or biofilm formation, or genes associated with fatty acid biosynthesis, and related compositions and methods of using the oligomers and compositions, for instance, in the treatment of an infected mammalian subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.